I

I Sens Inc
KOSDAQ:099190

Watchlist Manager
I Sens Inc
KOSDAQ:099190
Watchlist
Price: 15 980 KRW -2.2% Market Closed
Market Cap: 440.9B KRW

Profitability Summary

I Sens Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
I Sens Inc

Revenue
305.9B KRW
Cost of Revenue
-185.8B KRW
Gross Profit
120.1B KRW
Operating Expenses
-123B KRW
Operating Income
-2.9B KRW
Other Expenses
4.8B KRW
Net Income
1.9B KRW

Margins Comparison
I Sens Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
I Sens Inc
KOSDAQ:099190
441.7B KRW
39%
-1%
1%
US
Abbott Laboratories
NYSE:ABT
220.2B USD
56%
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
202.9B USD
66%
29%
29%
US
Boston Scientific Corp
NYSE:BSX
143.1B USD
69%
19%
14%
US
Stryker Corp
NYSE:SYK
137.2B USD
65%
22%
12%
IE
Medtronic PLC
NYSE:MDT
126.8B USD
66%
19%
14%
DE
Siemens Healthineers AG
XETRA:SHL
49.5B EUR
39%
14%
9%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.9B USD
62%
31%
25%
US
Becton Dickinson and Co
NYSE:BDX
56B USD
46%
16%
8%
US
Edwards Lifesciences Corp
NYSE:EW
49.8B USD
78%
28%
23%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.8B USD
41%
14%
11%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
I Sens Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
I Sens Inc
KOSDAQ:099190
441.7B KRW
1%
0%
-1%
0%
US
Abbott Laboratories
NYSE:ABT
220.2B USD
31%
18%
12%
20%
US
Intuitive Surgical Inc
NASDAQ:ISRG
202.9B USD
17%
15%
17%
22%
US
Boston Scientific Corp
NYSE:BSX
143.1B USD
13%
7%
11%
9%
US
Stryker Corp
NYSE:SYK
137.2B USD
14%
6%
14%
12%
IE
Medtronic PLC
NYSE:MDT
126.8B USD
10%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
49.5B EUR
12%
5%
10%
6%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.9B USD
65%
31%
58%
35%
US
Becton Dickinson and Co
NYSE:BDX
56B USD
7%
3%
7%
6%
US
Edwards Lifesciences Corp
NYSE:EW
49.8B USD
14%
10%
14%
16%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.8B USD
24%
6%
11%
8%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less